Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine

J Int Med Res. 2022 Sep;50(9):3000605221121956. doi: 10.1177/03000605221121956.

Abstract

Objective: This cross-sectional study investigated the circulating strains of rotavirus and screened for noravirus in Ibadan, Nigeria as the country introduces the rotavirus vaccine into its national immunization program.

Methods: Sixty-five stool samples were collected from children younger than 5 years with clinically diagnosed diarrhea and screened for the presence of rotavirus and norovirus using RT-PCR. Rotavirus-positive samples were further analyzed to determine the G and P genotypes using semi-nested multiplex PCR.

Results: The rates of rotavirus and norovirus positivity were 30.8% and 10.8%, respectively, whereas the rate of rotavirus and norovirus mixed infection was 4.6%. G1 was the predominant VP7 genotype, followed by G2, G9, and G1G2G9, whereas the predominant VP4 genotype was P[4], followed by P[6], P[8], and P[9]. The mixed P types P[4]P[8] and P[4]P[6] were also detected. G1P[4] was the most common VP4 and VP7 combination, followed by G2P[4], G1[P6], G1P[8], G2P[6], G2P[9], G9P[6], G2G9P[4], G2P[4]P[6], G1P[4]P[8], G2G9P[8], G1G2G9P[8], and G1[non-typable] P[non-typable], which were detected in at least 5% of the samples. Four samples had a combination of non-typable G and P types.

Conclusions: It is essential to monitor the circulation of virus strains prior to and during the implementation of the immunization program.

Keywords: Nigeria; Rotavirus; diarrhea; genotype; norovirus; pediatric; vaccine; viral gastroenteritis.

MeSH terms

  • Antigens, Viral / genetics
  • Capsid Proteins / genetics
  • Child, Preschool
  • Cross-Sectional Studies
  • Feces
  • Genetic Variation
  • Genotype
  • Humans
  • Nigeria / epidemiology
  • Norovirus* / genetics
  • Norovirus* / isolation & purification
  • Phylogeny
  • Rotavirus Infections* / diagnosis
  • Rotavirus Infections* / epidemiology
  • Rotavirus Infections* / prevention & control
  • Rotavirus Vaccines*
  • Rotavirus* / genetics

Substances

  • Antigens, Viral
  • Capsid Proteins
  • Rotavirus Vaccines